Express Scripts

NASDAQ: ESRX
$92.33
-$3.47 (-3.6%)
Closing price December 20, 2018
Express Scripts Holding Co. (NASDAQ: ESRX) reported fourth quarter financial results after the markets closed on Tuesday. The company had $1.56 in earnings per share (EPS) on $26.18 billion in...
Express Scripts is set to report its fourth-quarter financial results after the markets close on Tuesday.
In a fresh report, Janney Capital Markets has said that bad news for Horizon Pharma is creating a buying opportunity in DepoMed.
A surge in Apple shares sold short between the August 31 and September 15 settlement dates was the most notable move in among the most heavily shorted stocks traded on the Nasdaq.
The recent outcry on social media, focusing on drug pricing, is likely to draw attention to the role of pharmacy benefit managers.
Between the August 14 and August 31, Sirius XM was dethroned as the most heavily shorted stock traded on the Nasdaq.
A modest increase in short interest between the July 31 and August 14 settlement dates was enough for Sirius XM to reclaim the top spot on the list of the most heavily shorted stocks traded on the...
Between the July 15 and July 31 settlement dates, a modest increase in short interest was enough for AMD to rise to the top of the list of the most heavily shorted stocks traded on the Nasdaq.
Source: GallupAll of the top ten most shorted stocks on the NASDAQ had short interests of over 60 million shares, for the period which ended July 15. Not surprisingly, the largest industry...
Between the June 15 and June 30 settlement dates, the short interest increased in all but one of the six most heavily shorted stocks traded on the Nasdaq.
 These days, employees can easily share their work experiences online, and employee opinions about companies and managers are all readily available to prospective workers and customers alike. As a...
Between the May 15 and May 29 settlement dates, Sirius XM was dethroned as the most heavily shorted stock traded on the Nasdaq.
Between the May 15 and May 29 settlement dates, Mannkind continued its climb up the ranks of the most heavily shorted stocks traded on the Nasdaq.
Monday's top analyst upgrades, downgrades and initiations Include Ambev, CTI BioPharma, Duke, Humana, Occidental Petroleum and Yelp.
The five most heavily shorted stocks traded on the Nasdaq all saw increases in short interest between the April 30 and May 15 settlement dates.